25 results on '"Chopin V"'
Search Results
2. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21waf1
- Author
-
Chopin, V, Slomianny, C, Hondermarck, H, and Le Bourhis, X
- Published
- 2004
- Full Text
- View/download PDF
3. Statistics of the electric field strength in a controlled multipath environment
- Author
-
Leao, T. F. C., primary, Mooney-Chopin, V., additional, and Trueman, C. W., additional
- Published
- 2013
- Full Text
- View/download PDF
4. Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells
- Author
-
Lagadec, C, primary, Adriaenssens, E, additional, Toillon, R A, additional, Chopin, V, additional, Romon, R, additional, Van Coppenolle, F, additional, Hondermarck, H, additional, and Le Bourhis, X, additional
- Published
- 2007
- Full Text
- View/download PDF
5. Amino-acid-sequence determination and biological activity of cytin, a naturally occurring specific chymotrypsin inhibitor from the leech Theromyzon tessulatum
- Author
-
Chopin, V., Bilfinger, T. V., George Stefano, Matias, I., and Salzet, M.
6. Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment.
- Author
-
Winter M, Meignan S, Völkel P, Angrand PO, Chopin V, Bidan N, Toillon RA, Adriaenssens E, Lagadec C, and Le Bourhis X
- Subjects
- Animals, Cell Line, Tumor, Cell Movement physiology, Cyclophosphamide pharmacology, Disease Models, Animal, Drug Therapy methods, Epirubicin pharmacology, Epithelial-Mesenchymal Transition, Female, Humans, Neoadjuvant Therapy methods, Neoplasm Invasiveness pathology, Neoplasm Recurrence, Local, Paclitaxel therapeutic use, Triple Negative Breast Neoplasms pathology, Vimentin metabolism, Zebrafish, Drug Resistance, Neoplasm physiology, Triple Negative Breast Neoplasms metabolism, Vimentin physiology
- Abstract
Tremendous data have been accumulated in the effort to understand chemoresistance of triple negative breast cancer (TNBC). However, modifications in cancer cells surviving combined and sequential treatment still remain poorly described. In order to mimic clinical neoadjuvant treatment, we first treated MDA-MB-231 and SUM159-PT TNBC cell lines with epirubicin and cyclophosphamide for 2 days, and then with paclitaxel for another 2 days. After 4 days of recovery, persistent cells surviving the treatment were characterized at both cellular and molecular level. Persistent cells exhibited increased growth and were more invasive in vitro and in zebrafish model. Persistent cells were enriched for vimentin
high sub-population, vimentin knockdown using siRNA approach decreased the invasive and sphere forming capacities as well as Akt phosphorylation in persistent cells, indicating that vimentin is involved in chemotherapeutic treatment-induced enhancement of TNBC aggressiveness. Interestingly, ectopic vimentin overexpression in native cells increased cell invasion and sphere formation as well as Akt phosphorylation. Furthermore, vimentin overexpression alone rendered the native cells resistant to the drugs, while vimentin knockdown rendered them more sensitive to the drugs. Together, our data suggest that vimentin could be considered as a new targetable player in the ever-elusive status of drug resistance and recurrence of TNBC.- Published
- 2021
- Full Text
- View/download PDF
7. Expression and Prognostic Significance of Neurotrophins and Their Receptors in Canine Mammary Tumors.
- Author
-
Rogez B, Pascal Q, Bobillier A, Machuron F, Toillon RA, Tierny D, Chopin V, and Le Bourhis X
- Subjects
- Animals, Brain-Derived Neurotrophic Factor metabolism, Dogs, Immunohistochemistry veterinary, Lymph Nodes pathology, Neoplasm Grading, Neoplasm Metastasis pathology, Neoplasm Recurrence, Local veterinary, Nerve Growth Factor metabolism, Prognosis, Receptor, Nerve Growth Factor metabolism, Receptor, trkA metabolism, Receptor, trkB metabolism, Dog Diseases pathology, Mammary Neoplasms, Animal diagnosis, Mammary Neoplasms, Animal metabolism, Mammary Neoplasms, Animal pathology, Nerve Growth Factors metabolism
- Abstract
Accumulating data highlight the role of neurotrophins and their receptors in human breast cancer. This family includes nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), both synthetized as proneurotrophins (proNGF and proBDNF). (pro)NGF and (pro)BDNF initiate their biological effects by binding to both their specific receptors TrkA and TrkB, respectively, and the common receptor p75
NTR . Currently, no data are available about their expression and potential role in canine mammary tumors. The aim of this study was to investigate expression of proNGF and BDNF as well as their receptors TrkA, TrkB, and p75NTR in canine mammary carcinomas, and to correlate them with clinicopathological parameters (grade, histological type, lymph node status, recurrence, and distant metastasis) and survival. Immunohistochemistry was performed on serial sections of 96 canine mammary carcinomas with antibodies against proNGF, BDNF, TrkA, TrkB, and p75NTR . Of the 96 carcinomas, proNGF expression was detected in 71 (74%), BDNF in 79 (82%), TrkA in 94 (98%), TrkB in 35 (37%), and p75NTR in 44 (46%). No association was observed between proNGF, BDNF, or TrkA expression and either clinicopathological parameters or survival. TrkB and p75NTR expression were associated with favorable clinicopathological parameters as well as better overall survival.- Published
- 2020
- Full Text
- View/download PDF
8. ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2.
- Author
-
Lévêque R, Corbet C, Aubert L, Guilbert M, Lagadec C, Adriaenssens E, Duval J, Finetti P, Birnbaum D, Magné N, Chopin V, Bertucci F, Le Bourhis X, and Toillon RA
- Subjects
- Adaptor Proteins, Vesicular Transport metabolism, Animals, Antineoplastic Agents pharmacology, Brain Neoplasms enzymology, Brain Neoplasms prevention & control, Brain Neoplasms secondary, Breast Neoplasms genetics, Breast Neoplasms pathology, Breast Neoplasms therapy, Ephrin-A2 genetics, Female, Humans, MCF-7 Cells, Mice, SCID, Phosphorylation, Protein Binding, Protein Kinase Inhibitors pharmacology, RNAi Therapeutics, Receptor, EphA2, Receptor, trkA antagonists & inhibitors, Receptor, trkA genetics, Signal Transduction, Tumor Burden, Xenograft Model Antitumor Assays, src-Family Kinases metabolism, Breast Neoplasms enzymology, Cell Proliferation, Ephrin-A2 metabolism, Nerve Growth Factor metabolism, Protein Precursors metabolism, Receptor, trkA metabolism
- Abstract
ProNGF expression has been linked to several types of cancers including breast cancer, and we have previously shown that proNGF stimulates breast cancer invasion in an autocrine manner through membrane receptors sortilin and TrkA. However, little is known regarding TrkA-associated protein partners upon proNGF stimulation. By proteomic analysis and proximity ligation assays, we found that proNGF binding to sortilin induced sequential formation of the functional sortilin/TrkA/EphA2 complex, leading to TrkA-phosphorylation dependent Akt activation and EphA2-dependent Src activation. EphA2 inhibition using siRNA approach abolished proNGF-stimulated clonogenic growth of breast cancer cell lines. Combinatorial targeting of TrkA and EphA2 dramatically reduced colony formation in vitro, primary tumor growth and metastatic dissemination towards the brain in vivo. Finally, proximity ligation assay in breast tumor samples revealed that increased TrkA/EphA2 proximity ligation assay signals were correlated with a decrease of overall survival in patients. All together, these data point out the importance of TrkA/EphA2 functional association in proNGF-induced tumor promoting effects, and provide a rationale to target proNGF/TrkA/EphA2 axis by alternative methods other than the simple use of tyrosine kinase inhibitors in breast cancer., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
9. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
- Author
-
Rogez B, Pascal Q, Bobillier A, Machuron F, Lagadec C, Tierny D, Le Bourhis X, and Chopin V
- Subjects
- Animals, Dog Diseases metabolism, Dog Diseases mortality, Dog Diseases pathology, Dogs, Female, Mammary Glands, Animal metabolism, Mammary Glands, Animal pathology, Mammary Neoplasms, Animal metabolism, Mammary Neoplasms, Animal mortality, Mammary Neoplasms, Animal pathology, Prognosis, CD24 Antigen metabolism, Dog Diseases diagnosis, Hyaluronan Receptors metabolism, Mammary Neoplasms, Animal diagnosis
- Abstract
CD44
+ /CD24- phenotype has been used to identify human and canine mammary cancer stem-like cells. In canine mammary tumors, CD44+ /CD24- phenotype has been associated with high grade and lymph node infiltration. However, several studies have reported opposing results regarding the clinical significance of phenotypic groups formed by the combination of CD44 and CD24 in both human and canine mammary tumors. So far, no study has investigated the correlation between these phenotypes and survival in dogs. The aim of this study was to investigate the expression and distribution of CD44 and CD24 in canine mammary carcinomas and to correlate them with histological diagnosis and survival in a well-characterized cohort. Immunohistochemistry was performed in 96 mammary carcinomas with antibodies against CD44 and CD24. Expression of CD44+ and CD44+ /CD24- phenotype was detected in 75 of 96 (78%) and 63 of 96 (65.6%) carcinomas, respectively. Their expression was associated with tumor type, occurring more often in tubular complex carcinomas than in solid carcinomas. CD44+ /CD24- phenotype was associated with a better overall survival ( P = .001). CD24+ expression was detected in 52 of 96 tumors (54%) and CD44- /CD24+ phenotype in 39 of 96 tumors (40.6%). Both were associated with poor clinicopathological parameters (high grade, and emboli). No correlation with overall survival was observed. CD44+ /CD24- expression was associated with a better prognosis and occurred at high frequency and high level, indicating that this phenotype is not suitable to detect cancer stem cells in canine mammary carcinomas. Although further studies are needed, our results suggest that CD24 may constitute a valuable marker of poor prognosis for canine mammary carcinomas.- Published
- 2019
- Full Text
- View/download PDF
10. Neurotrophin signaling in cancer stem cells.
- Author
-
Chopin V, Lagadec C, Toillon RA, and Le Bourhis X
- Subjects
- Animals, Brain-Derived Neurotrophic Factor metabolism, Epithelial-Mesenchymal Transition, Humans, Neoplastic Stem Cells cytology, Receptors, Nerve Growth Factor metabolism, Signal Transduction, Neoplastic Stem Cells metabolism, Nerve Growth Factors metabolism
- Abstract
Cancer stem cells (CSCs), are thought to be at the origin of tumor development and resistance to therapies. Thus, a better understanding of the molecular mechanisms involved in the control of CSC stemness is essential to the design of more effective therapies for cancer patients. Cancer cell stemness and the subsequent expansion of CSCs are regulated by micro-environmental signals including neurotrophins. Over the years, the roles of neurotrophins in tumor development have been well established and regularly reviewed. Especially, nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are reported to stimulate tumor cell proliferation, survival, migration and/or invasion, and favors tumor angiogenesis. More recently, neurotrophins have been reported to regulate CSCs. This review briefly presents neurotrophins and their receptors, summarizes their roles in different cancers, and discusses the emerging evidence of neurotrophins-induced enrichment of CSCs as well as the involved signaling pathways.
- Published
- 2016
- Full Text
- View/download PDF
11. Human ether à-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry.
- Author
-
Hammadi M, Chopin V, Matifat F, Dhennin-Duthille I, Chasseraud M, Sevestre H, and Ouadid-Ahidouch H
- Subjects
- Breast Neoplasms metabolism, Breast Neoplasms pathology, Calcium Channels genetics, Carcinoma, Ductal, Breast metabolism, Carcinoma, Ductal, Breast pathology, Cell Line, Tumor, Cell Survival, Ether-A-Go-Go Potassium Channels genetics, Female, Gene Expression Regulation, Neoplastic physiology, Humans, Immunohistochemistry, Lymph Nodes pathology, Manganese, Neoplasm Invasiveness, ORAI1 Protein, Patch-Clamp Techniques, RNA Interference, Reverse Transcriptase Polymerase Chain Reaction, Calcium metabolism, Calcium Channels metabolism, Cell Movement physiology, Ether-A-Go-Go Potassium Channels metabolism
- Abstract
Breast cancer (BC) has a poor prognosis due to its strong metastatic ability. Accumulating data present ether à go-go (hEag1) K(+) channels as relevant player in controlling cell cycle and proliferation of non-invasive BC cells. However, the role of hEag1 in invasive BC cells migration is still unknown. In this study, we studied both the functional expression and the involvement in cell migration of hEag1 in the highly metastatic MDA-MB-231 human BC cells. We showed that hEag1 mRNA and proteins were expressed in human invasive ductal carcinoma tissues and BC cell lines. Functional activity of hEag1 channels in MDA-MB-231 cells was confirmed using astemizole, a hEag1 blocker, or siRNA. Blocking or silencing hEag1 depolarized the membrane potential and reduced both Ca(2+) entry and MDA-MB-231 cell migration without affecting cell proliferation. Recent studies have reported that Ca(2+) entry through Orai1 channels is required for MDA-MB-231 cell migration. Down-regulation of hEag1 or Orai1 reduced Ca(2+) influx and cell migration with similar efficiency. Interestingly, no additive effects on Ca(2+) influx or cell migration were observed in cells co-transfected with sihEag1 and siOrai1. Finally, both Orai1 and hEag1 are expressed in invasive breast adenocarcinoma tissues and invaded metastatic lymph node samples (LNM(+)). In conclusion, this study is the first to demonstrate that hEag1 channels are involved in the serum-induced migration of BC cells by controlling the Ca(2+) entry through Orai1 channels. hEag1 may therefore represent a potential target for the suppression of BC cell migration, and thus prevention of metastasis development., (Copyright © 2012 Wiley Periodicals, Inc.)
- Published
- 2012
- Full Text
- View/download PDF
12. Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells.
- Author
-
Faouzi M, Chopin V, Ahidouch A, and Ouadid-Ahidouch H
- Subjects
- Breast Neoplasms metabolism, Breast Neoplasms pathology, Calcium pharmacology, Cell Line, Tumor, Cell Proliferation drug effects, Clotrimazole pharmacology, Female, Humans, Intermediate-Conductance Calcium-Activated Potassium Channels drug effects, Prolactin pharmacology, Pyrazoles, Tyrphostins pharmacology, Intermediate-Conductance Calcium-Activated Potassium Channels physiology, Janus Kinase 2 physiology, Receptors, Prolactin physiology
- Abstract
Prolactin (PRL) is a polypeptidic hormone which acts both systemically and locally to cause lactation by interacting with the PRL receptor, a Janus kinase (JAK2)-coupled cytokine receptor family member. Several studies have reported that serum PRL level elevation is associated with an increased risk for breast cancer, and evidence has suggested that PRL is one actor in the pathogenesis and progression of this cancer. We previously reported the involvement of hIKCa1 in breast cell cycle progression and cell proliferation. However, mechanisms by which PRL cooperates with these channels to modulate breast epithelial cell proliferation remain unknown. Our results showed that, in the MCF-7 breast cancer cell line, PRL increased hIKCa1 current density. These channels were functional and regulated the resting membrane potential. The PRL effects were inhibited by TRAM-34 and clotrimazole, the most used hIKCa1 blockers. Moreover, PRL increased proliferation in a dose-dependent manner without overexpressing hIKCa1. To determine whether PRL-induced proliferation and hIKCa1 activity involved the JAK2 pathway, we used pharmacological JAK2 inhibitors (AG490 and JAK inhibitor I). Indeed, PRL-induced JAK2 phosphorylation was required for both cell proliferation and hIKCa1 activity. In the presence of either hIKCa1 blockers or siRNA-hIKCa1, PRL failed to increase cell proliferation and hIKCa1 activity. Taken together, our results demonstrate that PRL plays a role in breast cancer cell proliferation by increasing hIKCa1 activity through the JAK2 signaling pathway.
- Published
- 2010
- Full Text
- View/download PDF
13. Proteomics demonstration that normal breast epithelial cells can induce apoptosis of breast cancer cells through insulin-like growth factor-binding protein-3 and maspin.
- Author
-
Toillon RA, Lagadec C, Page A, Chopin V, Sautière PE, Ricort JM, Lemoine J, Zhang M, Hondermarck H, and Le Bourhis X
- Subjects
- Adolescent, Adult, Amino Acid Sequence, Breast Neoplasms metabolism, Cells, Cultured, Culture Media, Conditioned, Epithelial Cells metabolism, Female, Humans, Molecular Sequence Data, Proteomics, Tandem Mass Spectrometry, Apoptosis physiology, Breast Neoplasms pathology, Epithelial Cells physiology, Insulin-Like Growth Factor Binding Protein 3 physiology, Serpins physiology
- Abstract
Normal breast epithelial cells are known to exert an apoptotic effect on breast cancer cells, resulting in a potential paracrine inhibition of breast tumor development. In this study we purified and characterized the apoptosis-inducing factors secreted by normal breast epithelial cells. Conditioned medium was concentrated by ultrafiltration and separated on reverse phase Sep-Pak C18 and HPLC. The proapoptotic activity of eluted fractions was tested on MCF-7 breast cancer cells, and nano-LC-nano-ESI-MS/MS allowed the identification of insulin-like growth factor-binding protein-3 (IGFBP-3) and maspin as the proapoptotic factors produced by normal breast epithelial cells. Western blot analysis of conditioned media confirmed the specific secretion of IGFBP-3 and maspin by normal cells but not by breast cancer cells. Immunodepletion of IGFBP-3 and maspin completely abolished the normal cell-induced apoptosis of cancer cells, and recombinant proteins reproduced the effect of normal cell-conditioned medium on apoptosis of breast cancer cells. Together our results indicated that normal breast epithelial cells can induce apoptosis of breast cancer cells through IGFBP-3 and maspin. These findings provide a molecular hypothesis for the long observed inhibitory effect of normal surrounding cells on breast cancer development.
- Published
- 2007
- Full Text
- View/download PDF
14. [Chromosome arm 17p13.3: could HIC1 be the one ?].
- Author
-
Chopin V and Leprince D
- Subjects
- Animals, Chromosome Mapping, Disease Models, Animal, Genetic Markers, Histone Deacetylases metabolism, Humans, Kruppel-Like Transcription Factors, Loss of Heterozygosity, Mice, Neoplasms genetics, Tumor Suppressor Protein p53 genetics, Chromosomes, Human, Pair 17, DNA-Binding Proteins genetics, Transcription Factors genetics
- Abstract
Loss of heterozygosity (LOH) of the short arm of chromosome 17 (17p) is one of the most frequent genetic alterations in human cancers. Most often, allelic losses coincide with p53 mutations at 17p13.1. However, in many types of solid tumors including sporadic breast cancers, ovarian cancers, medulloblastomas and small cell lung carcinomas, frequent LOH or DNA methylation changes occur in a more telomeric region at 17p13.3, in absence of any p53 genetic alterations. These results suggest that one or more tumor suppressor genes located at 17p13.3 could be involved in tumorigenesis. In addition, the 17p13.3 region has also been implicated in the Miller-Dieker syndrome (MDS), a severe form of lissencephaly accompanied by developmental anomalies caused by heterozygous gene deletions. Analyses of deletion mapping and CpG island methylation patterns have resulted in the identification of two tumor suppressor genes at 17p13.3, HIC1 (hypermethylated in cancer 1) and OVCA1 (ovarian cancer gene 1). HIC1 is a tumor suppressor gene that encodes a transcriptional repressor with five Krüppel-like C2H2 zinc finger motifs and a N-terminal BTB/POZ domain. Clues to the tumor suppressor function of HIC1 have come from the study of heterozygous Hic1+/- mice, which develop spontaneous malignant tumors of different types. Generation of double heterozygous knockout mice Hic1+/- p53+/- provides strong evidence that epigenetically silenced genes such as HIC1 can significantly influence tumorigenesis driven by mutations of classic tumor suppressor genes. This functional cooperation between HIC1 and p53 is interesting and recently, its has been demonstrated that HIC1 was involved in a certain feedback regulation for p53 in tumor suppression through the histone deacetylase SIRT1. However, despite the fact that epigenetic oncogenesis is one of the most vibrant areas of biologic research, the determinants between genetic versus epigenetic routes of tumor suppressor gene inactivation remain elusive.
- Published
- 2006
- Full Text
- View/download PDF
15. [Epigenetics and cancer].
- Author
-
Deltour S, Chopin V, and Leprince D
- Subjects
- Animals, DNA Methylation, Histones genetics, Humans, Epigenesis, Genetic, Neoplasms genetics
- Abstract
Epigenetics is defined as "the study of mitotically and/or meiotically heritable changes in gene expression that cannot be explained by changes in the DNA sequence". Setting up the epigenetic program is crucial for correct development and its stable inheritance throughout its lifespan is essential for the maintenance of the tissue- and cell-specific functions of the organism. For many years, the genetic causes of cancer have hold centre stage. However, the recent wealth of information about the molecular mechanisms which, by modulating the chromatin structure, can regulate gene expression has high-lighted the predominant role of epigenetic modifications in the initiation and progression of numerous pathologies, including cancer. The nucleosome is the major target of these epigenetic regulation mechanisms. They include a series of tightly interconnected steps which starting with the setting ("writing") of the epigenetic mark till its "reading" and interpretation will result in long-term gene regulation. The major epigenetic changes associated with tumorigenesis are aberrant DNA methylation of CpG islands located in the promoter region of tumor suppressor gene, global genomic hypomethylation and covalent modifications of histone N-terminal tails which are protruding out from the nucleosome core. In sharp contrast with genetic modifications, epigenetic modifications are highly dynamic and reversible. The characterization of specific inhibitors directed against some key epigenetic players has opened a new and promising therapeutic avenue, the epigenetic therapy, since some inhibitors are already used in clinical trials.
- Published
- 2005
- Full Text
- View/download PDF
16. P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells.
- Author
-
Chopin V, Toillon RA, Jouy N, and Le Bourhis X
- Subjects
- Breast Neoplasms pathology, Cell Line, Tumor, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinases antagonists & inhibitors, Cyclins analysis, DNA Repair, Female, Humans, Plasmids, Proliferating Cell Nuclear Antigen analysis, Apoptosis drug effects, Butyrates pharmacology, Cyclins physiology, G1 Phase drug effects
- Abstract
Sodium butyrate (NaB) has been proposed as a potential anticancer agent. However, its mechanism of action is not totally elucidated. Here, we showed that NaB-induced cell cycle arrest and apoptosis were associated with an increase of P21(waf1/cip1) in MCF-7 breast cancer cells. This increase was more important in the nuclei, as revealed by immunofluorescence analysis. Transient transfections of MCF-7 cells with p21 deficient for interaction with CDK, but not with p21 deficient for interaction with PCNA (p21PCNA-), abrogated NaB-induced cell cycle arrest. This indicated that cell cycle blockage involved the interaction of P21(waf1/cip1) with CDK. However, P21(waf1/cip1) was dispensable, since p21 antisense did not modify cell cycle arrest. On the other hand, NaB-induced apoptosis was abolished by p21 antisense or p21PCNA-. In addition, NaB decreased PCNA levels, but increased the association of PCNA with P21(waf1/cip1). These results suggested that NaB-induced apoptosis required P21(waf1/cip1) and its interaction with PCNA.
- Published
- 2004
- Full Text
- View/download PDF
17. (-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts.
- Author
-
Vergote D, Cren-Olivé C, Chopin V, Toillon RA, Rolando C, Hondermarck H, and Le Bourhis X
- Subjects
- Breast cytology, Breast metabolism, Breast Neoplasms genetics, Caspases metabolism, Cell Cycle drug effects, Cyclin D1 analysis, Dose-Response Relationship, Drug, Fatty Acid Synthases metabolism, Female, Humans, Proto-Oncogene Proteins analysis, Tumor Cells, Cultured drug effects, Tumor Cells, Cultured metabolism, bcl-2-Associated X Protein, Apoptosis drug effects, Breast Neoplasms metabolism, Catechin analogs & derivatives, Catechin pharmacology, Proto-Oncogene Proteins c-bcl-2
- Abstract
(-)-Epigallocatechin (EGC), one of green tea polyphenols, has been shown to inhibit growth of cancer cells. However its mechanism of action is poorly known. We show here that EGC strongly inhibited the growth of breast cancer cell lines (MCF-7 and MDA-MB-231) but not that of normal breast epithelial cells. The inhibition of breast cancer cell growth was due to an induction of apoptosis, without any change in cell cycle progression. MCF-7 cells are known to express a wild-type p53 whereas MDA-MB-231 cells express a mutated p53. The fact that EGC induced apoptosis in both these cell lines suggests that the EGC-triggered apoptosis is independent of p53 status. Moreover, neutralizing antibodies against the death receptor Fas and inhibitors of caspases, such as caspase-8 and -10, efficiently inhibited the EGC-triggered apoptosis. In addition, immunoblotting revealed that EGC treatment was correlated with a decrease in Bcl-2 and an increase in Bax level. These results suggest that EGC-triggered apoptosis in breast cancer cells requires Fas signaling.
- Published
- 2002
- Full Text
- View/download PDF
18. Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells.
- Author
-
Toillon RA, Chopin V, Jouy N, Fauquette W, Boilly B, and Le Bourhis X
- Subjects
- Blotting, Western, Breast cytology, Breast Neoplasms metabolism, Cells, Cultured, Coculture Techniques, Culture Media, Conditioned pharmacology, Cyclin-Dependent Kinase Inhibitor p21, Cyclins genetics, Female, Gene Expression Regulation, Neoplastic, Humans, Tumor Cells, Cultured, Apoptosis drug effects, Breast metabolism, Breast Neoplasms pathology, Cell Cycle drug effects, Epithelial Cells metabolism, Tumor Suppressor Protein p53 genetics
- Abstract
Cancer development depends not only on the nature of cancerous cells themselves, but also on the regulatory effects of various normal cells. The present study was performed to investigate the effect of normal breast epithelial cells (NBEC) on the growth of breast cancer cells under various conditions. We demonstrated that NBEC-conditioned medium (NBEC-CM) inhibited growth of breast cancer cell lines in monolayer culture and three-dimensional collagen gel culture, as well as in soft agar. In MCF-7 and T-47D cells which have a functional p53, NBEC-CM induced apoptosis without modifying cell cycle progression. In MDA-MB-231 and BT-20 cells that have a non-functional p53, NBEC-CM did not induce apoptosis, although a slight G1 blokage was observed in MDA-MB-231 cells. Transient transfections of MCF-7 and T-47D cells demonstrated that NBEC-triggered apoptosis was mediated by endogenous p53. Moreover, pifithrin-alpha which specifically inhibits the transcriptional activity of p53, completely abolished NBEC-induced apoptosis in both MCF-7 and T-47D cells, indicating that p53 mediated apoptosis via its transcriptional activity. Finally, orthovanadate, a protein tyrosine phosphatase inhibitor, completely inhibited NBEC-triggered apoptosis, indicating that NBEC-triggered apoptosis was regulated by tyrosine phosphatases.
- Published
- 2002
- Full Text
- View/download PDF
19. Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells.
- Author
-
Chopin V, Toillon RA, Jouy N, and Le Bourhis X
- Subjects
- Apoptosis physiology, Benzothiazoles, Blotting, Western, Breast Neoplasms physiopathology, Caspase Inhibitors, Cell Cycle drug effects, Cell Division drug effects, Fas Ligand Protein, Humans, Membrane Glycoproteins drug effects, Membrane Glycoproteins metabolism, Proto-Oncogene Proteins drug effects, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins c-bcl-2 drug effects, Proto-Oncogene Proteins c-bcl-2 metabolism, Signal Transduction, Thiazoles pharmacology, Toluene analogs & derivatives, Toluene pharmacology, Tumor Cells, Cultured drug effects, bcl-2-Associated X Protein, fas Receptor drug effects, Apoptosis drug effects, Breast Neoplasms metabolism, Butyrates pharmacology, Tumor Suppressor Protein p53 physiology, fas Receptor metabolism
- Abstract
1. This study was performed to determine the effect and action mechanisms of sodium butyrate (NaB) on the growth of breast cancer cells. 2. Butyrate inhibited the growth of all breast cancer cell lines analysed. It induced cell cycle arrest in G1 and apoptosis in MCF-7, MCF-7ras, T47-D, and BT-20 cells, as well as arrest in G2/M in MDA-MB-231 cells. 3. Transient transfection of MCF-7 and T47-D cells with wild-type and antisense p53 did not modify butyrate-induced apoptosis. Pifithrin-alpha, which inhibits the transcriptional activity of P53, did not modify cell growth or apoptosis of MCF-7 and T47-D cells treated with butyrate. These results indicate that P53 was not involved in butyrate-induced growth inhibition of breast cancer cells. 4. Treatment of MCF-7 cells with anti-Fas agonist antibody induced cell death, indicating that Fas was functional in these cells. Moreover, butyrate potentiated Fas-induced apoptosis, as massive apoptosis was observed rapidly when MCF-7 cells were treated with butyrate and anti-Fas agonist antibody. In addition, butyrate-induced apoptosis in MCF-7 cells was considerably reduced by anti-Fas antagonist antibody. Western blot analysis showed that butyrate increased Fas and Fas ligand levels (Fas L), indicating that butyrate-induced apoptosis may be mediated by Fas signalling. 5. These results demonstrate that butyrate inhibited the growth of breast cancer cells in a P53-independent manner. Moreover, it induced apoptosis via the Fas/Fas L system and potentiated Fas-triggered apoptosis in MCF-7 cells. These findings may open interesting perspectives in human breast cancer treatment strategy.
- Published
- 2002
- Full Text
- View/download PDF
20. Therostasin, a novel clotting factor Xa inhibitor from the rhynchobdellid leech, Theromyzon tessulatum.
- Author
-
Chopin V, Salzet M, Baert Jl, Vandenbulcke F, Sautiére PE, Kerckaert JP, and Malecha J
- Subjects
- Amino Acid Sequence, Animals, Anticoagulants isolation & purification, Base Sequence, Chromatography, Gel, Invertebrate Hormones chemistry, Mammals, Molecular Sequence Data, Proteins isolation & purification, RNA, Messenger analysis, Sequence Alignment, Sequence Homology, Amino Acid, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Anticoagulants chemistry, Factor Xa Inhibitors, Leeches genetics, Proteins chemistry, Proteins genetics
- Abstract
Therostasin is a potent naturally occurring tight-binding inhibitor of mammalian Factor Xa (K(i), 34 pm), isolated from the rhynchobdellid leech Theromyzon tessulatum. Therostasin is a cysteine-rich protein (8991 Da) consisting of 82 amino acid residues with 16 cysteine residues. Its amino acid sequence has been determined by a combination of techniques, including Edman degradation, enzymatic cleavage, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) on the native and s-beta-pyridylethylated compound. Sequence analysis reveals that it shares no significant homology with other Factor Xa inhibitors except for the putative reactive site. Moreover, it contains a signature pattern for proteins of the endothelin family, potent vasoconstrictors isolated in mammal and snake venom. Therostasin cDNA (825 bp) codes for a polypeptide of 82 amino acid residues preceded by 19 residues, representing a signal peptide sequence. As for the other known inhibitors of Factor Xa, therostasin is expressed and stored in the cells of the leech salivary glands.
- Published
- 2000
- Full Text
- View/download PDF
21. Theromin, a novel leech thrombin inhibitor.
- Author
-
Salzet M, Chopin V, Baert J, Matias I, and Malecha J
- Subjects
- Amino Acid Sequence, Amino Acids chemistry, Animals, Aprotinin pharmacology, Chromatography, Gel, Chromatography, High Pressure Liquid, Chromatography, Ion Exchange, Dose-Response Relationship, Drug, Electrophoresis, Polyacrylamide Gel, Granulocytes drug effects, Granulocytes metabolism, Kinetics, Leeches, Lipopolysaccharides metabolism, Lymphocyte Activation drug effects, Molecular Sequence Data, Monocytes drug effects, Monocytes metabolism, Peptides chemistry, Proteins isolation & purification, Proteins pharmacology, Proteins physiology, Sequence Homology, Amino Acid, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Time Factors, Proteins chemistry, Thrombin antagonists & inhibitors
- Abstract
We purified the most potent thrombin inhibitor described to date from the rhynchobdellid leech Theromyzon tessulatum. Designated theromin, it was purified to apparent homogeneity by gel permeation and anion exchange chromatography followed by two reverse-phase steps of high performance liquid chromatography. The primary sequence of theromin (a homodimer of 67 amino acid residues including 16 cysteine residues) was determined by a combination of reduction and s-beta-pyridylethylation, Edman degradation, trypsin enzymatic digestion, and matrix-assisted laser desorption mass spectrometry measurement. Theromin exhibits no sequence homology with any other thrombin inhibitors. Furthermore, theromin significantly diminishes, in a dose-dependent manner, the level of human granulocyte and monocyte activation induced by lipopolysaccharides. In summary, this potent thrombin inhibitor promises to have high biomedical significance.
- Published
- 2000
- Full Text
- View/download PDF
22. Biochemical evidence of specific trypsin-chymotrypsin inhibitors in the rhynchobdellid leech, Theromyzon tessulatum.
- Author
-
Chopin V, Stefano G, and Salzet M
- Subjects
- Amino Acid Sequence, Amino Acids chemistry, Animals, Chromatography, Gel, Chromatography, High Pressure Liquid, Electrophoresis, Capillary, Electrophoresis, Polyacrylamide Gel, Enzyme Inhibitors isolation & purification, Molecular Sequence Data, Peptides chemistry, Sequence Analysis, Protein, Serine Proteinase Inhibitors isolation & purification, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Substrate Specificity, Trypsin Inhibitors chemistry, Chymotrypsin antagonists & inhibitors, Enzyme Inhibitors pharmacology, Leeches chemistry, Serine Proteinase Inhibitors pharmacology, Trypsin drug effects
- Abstract
The presence of two specific trypsin-chymotrypsin inhibitors from head parts of the rhynchobdellid leech Theromyzon tessulatum is reported. Two proteins, anti-trypsin chymotrypsin A (ATCA; 14636.6 +/- 131 Da) and anti-trypsin-chymotrypsin B (ATCB; 14368 +/- 95 Da) were purified by size exclusion and anion-exchange chromatography followed by reversed-phase HPLC. Based on amino-acid composition, N-terminal sequence determination (MELCELGQSCSRD-NPQPSNM), matrix assisted laser desorption-time of flight measurement (MALDI-TOF), trypsin mapping comparison, inhibition constant determination (Ki), and influence on amidolytic activity of different serine proteases, it is demonstrated that ATCA and ATCB are novel and highly potent serine-protease inhibitors of trypsin and chymotrypsin (ATCA: 350fM towards trypsin and chymotrypsin; ATCB: 400 and 75 fM towards trypsin and chymotrypsin, respectively). It is further surmised that ATCA and ATCB are linked, in that ATCB would lead to the formation of ATCA after loss of few amino acid residues.
- Published
- 2000
- Full Text
- View/download PDF
23. Amino-acid-sequence determination and biological activity of tessulin, a naturally occurring trypsin-chymotrypsin inhibitor isolated from the leech Theromyzon tessulatum.
- Author
-
Chopin V, Stefano GB, and Salzet M
- Subjects
- Adjuvants, Immunologic pharmacology, Amino Acid Sequence, Animals, Binding Sites, Chymotrypsin antagonists & inhibitors, Electrophoresis, Capillary, Inflammation drug therapy, Leukocytes drug effects, Lipopolysaccharides pharmacology, Molecular Sequence Data, Proteins chemistry, Sequence Analysis, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Trypsin Inhibitors chemistry, Leeches chemistry, Peptides chemistry, Serine Proteinase Inhibitors chemistry
- Abstract
We purified a new trypsin-chymotrypsin inhibitor, designated tessulin, from the rhynchobdellid leech Theromyzon tessulatum. This 9-kDa peptide was purified to apparent homogeneity by gel-permeation and anion-exchange chromatographies followed by reverse-phase HPLC. The structure of tessulin was determined by reduction, S-beta-pyridylethylation, trypsin digestion, automated Edman degradation and matrix-assisted laser desorption mass spectrometry (m/z 8985 Da). The 81-amino-acid peptide possesses 16 cysteines and exhibits a 16% sequence similarity with antistasin-type inhibitors. Tessulin inhibits trypsin (Ki 1 pM) and chymotrypsin (Ki 150 pM) and exhibits no activity with thrombin, factor Xa, cathepsin G and elastase. This is the first trypsin-chymotrypsin inhibitor isolated from leeches that does not inhibit elastase or cathepsin G, except for cytin and therin. Furthermore, tessulin, in conjunction with other serine-protease inhibitors isolated from Theromyzon (therin, theromin), significantly diminishes the level of human granulocyte and monocyte activation induced by lipopolysaccharides (10 microg). The combined level of inhibition is higher than that of aprotinin, another serine-protease inhibitor used biomedically. Thus, tessulin may be clinically significant in reducing inflammatory events.
- Published
- 1998
- Full Text
- View/download PDF
24. Amino acid sequence determination and biological activity of therin, a naturally occuring specific trypsin inhibitor from the leech Theromyzon tessulatum.
- Author
-
Chopin V, Matias I, Stefano GB, and Salzet M
- Subjects
- Adjuvants, Immunologic pharmacology, Amino Acid Sequence, Animals, Cells, Cultured, Chromatography, Gel, Chromatography, High Pressure Liquid, Chromatography, Ion Exchange, Humans, Leukocytes drug effects, Molecular Sequence Data, Oligopeptides isolation & purification, Oligopeptides pharmacology, Trypsin Inhibitors pharmacology, Leeches chemistry, Oligopeptides chemistry, Trypsin Inhibitors chemistry
- Abstract
We purified a trypsin inhibitor, designated therin, from the rhynchobdellid leech Theromyzon tessulatum. Therin was purified to apparent homogeneity by gel-permeation and anion-exchange chromatography followed by reverse-phase HPLC. By a combination of reduction and S-beta-pyridylethylation, Edman degradation and electrospray mass spectrometry measurement, the complete sequence of therin (48 amino acid residues; m/z, 5376.35 +/- 0.22 Da) was determined. Therin exhibits an approximately 30% sequence similarity with peptides of the antistasin-type inhibitors family, i.e. the first and second domains of antistasin, hirustasin, ghilanthen and guamerins (I, II). Therin is a tight-binding inhibitor of trypsin (Ki, 45 +/- 12 pM) and has no action towards elastase or cathepsin G. Furthermore, therin (10(-6) M) in conjunction with theromin, a Theromyzon thrombin inhibitor (10(-6) M) significantly diminish the level of human leucocytes activation induced by lipopolysaccharide (10 microg) in a manner similar to that of aprotinin. These data suggest a leech trypsin inhibitor with possible biomedical significance.
- Published
- 1998
- Full Text
- View/download PDF
25. Amino-acid-sequence determination and biological activity of cytin, a naturally occurring specific chymotrypsin inhibitor from the leech Theromyzon tessulatum.
- Author
-
Chopin V, Bilfinger TV, Stefano GB, Matias I, and Salzet M
- Subjects
- Amino Acid Sequence, Animals, Aprotinin pharmacology, Chromatography, High Pressure Liquid, Electrophoresis, Capillary, Granulocytes drug effects, Granulocytes physiology, Humans, Lipopolysaccharides antagonists & inhibitors, Lipopolysaccharides pharmacology, Mass Spectrometry, Molecular Sequence Data, Monocytes drug effects, Monocytes physiology, Peptides chemistry, Peptides isolation & purification, Peptides pharmacology, Proteins isolation & purification, Proteins pharmacology, Sequence Analysis, Serine Proteinase Inhibitors isolation & purification, Serine Proteinase Inhibitors pharmacology, Substrate Specificity, Chymotrypsin antagonists & inhibitors, Leeches chemistry, Proteins chemistry, Serine Proteinase Inhibitors chemistry
- Abstract
We purified a chymotrypsin inhibitor, designated cytin, from the rhynchobdellid leech Theromyzon tessulatum. This 7.4-kDa peptide was purified to apparent homogeneity by gel-permeation and anion-exchange chromatographies, followed by reverse-phase HPLC. The structure of cytin was determined by reduction, S-beta-pyridilethylation, automated Edman degradation, and electrospray mass spectrometry. Cytin is formed by the association of two protein chains, which are linked by a disulfide bridge. Chain A consists of 43 and chain B of 22 amino acid residues. Chain B exhibits 40-63% sequence similarity with the N-terminal sequences of subtilisin/chymotrypsin inhibitors isolated from barley seeds. Cytin inhibited chymotrypsin (Ki 600 pM) and weakly inhibited trypsin (Ki 350 nM). This chymotrypsin inhibitor, in contrast to others isolated from leeches, does not inhibit elastase or cathepsin G. Furthermore, cytin (10 microM) significantly diminishes the level of human granulocyte and monocyte activation induced by lipopolysaccharide (1 U/ml) in a manner similar to that of aprotinin. These data indicate that this chymotrypsin inhibitor may be biomedically significant.
- Published
- 1997
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.